DEFINITION of 'Present Value Interest Factor  PVIF'
A factor that can be used to simplify the calculation for finding the present value of a series of values. PVIFs can be presented in the form of a table with PVIF values seperated by respective period and interest rate combinations.
The 'r' represents the discount interest rate, and the 't' represents the number of periods.
INVESTOPEDIA EXPLAINS 'Present Value Interest Factor  PVIF'
Using the PVIF works best when you are attempting to discount one value in the future. For example, assume you are going to receive $5,000 in four years time, with the current discount interest rate being 8%. Using the standard present value formula the calculation would be $5,000 / (1+.08)^{4 }.
This would result in a present value of approximately $3,675.15. By using a PVIF table, an individual can identify the factor for this calculation being 0.73503 (calculated: 1/(1.08^4)). They can then multiply the $5,000 by 0.73503, which results in $3675.15 as well. This is another way to come to the same answer as the standard present value formula, but becomes a useful technique when you are comparing or dealing with a large number of values.

Net Present Value  NPV
The difference between the present value of cash inflows and ... 
Present Value Of An Annuity
The current value of a set of cash flows in the future, given ... 
Future Value Of An Annuity
The value of a group of payments at a specified date in the future. ... 
Present Value Interest Factor Of ...
A factor which can be used to calculate the present value of ... 
Discounted Cash Flow  DCF
A valuation method used to estimate the attractiveness of an ... 
Interest Rate
The amount charged, expressed as a percentage of principal, by ...

What are the disadvantages of using net present value as an investment criterion?
While net present value (NPV) calculations are useful when you are valuing investment opportunities, the process is by no ... Read Full Answer >> 
What's the difference between net present value and internal rate of return? How ...
Both of these measurements are primarily used in capital budgeting, the process by which companies determine whether a new ... Read Full Answer >> 
Which is a better measure for capital budgeting, IRR or NPV?
In capital budgeting, there are a number of different approaches that can be used to evaluate any given project, and each ... Read Full Answer >>

Fundamental Analysis
Discounted Cash Flow Analysis
Find out how analysts determine the fair value of a company with this stepbystep tutorial and learn how to evaluate an investment's attractiveness for yourself. 
Investing Basics
Calculating The Present And Future Value Of Annuities
At some point in your life, you may have had to make a series of fixed payments over a period of time  such as rent or car payments  or have received a series of payments over a period of time, ... 
Investing Basics
Understanding The Time Value Of Money
Find out why time really is money by learning to calculate present and future value. 
Charts & Patterns
Why These Could Be 2015's 10 Best Biotech Stocks
A quick look at a 10 biotech companies that are poised to deliver for shareholders in 2015. 
Fundamental Analysis
What is a Null Hypothesis?
In statistics, a null hypothesis is assumed true until proven otherwise. 
Charts & Patterns
Why These Could Be 2015's 10Best Media Stocks
A list of toptier and speculative media stocks for 2015. 
Stock Analysis
Is This Dividend Stock A Value Or Value Trap?
We can say that Fifth Street Finance has had a rough year, but there's a huge difference between an undervalued stock and a stock that's cheap for a reason 
Charts & Patterns
Why These Could Be 2015's 10Best Pharma Stocks
The pharmaceutical stocks covered here have significant potential going forward. Here's why. 
Charts & Patterns
Why These Are 2015's 10Best Financial Stocks
If you're going to invest in the financial stocks, these names need to be on your radar. 
Stock Analysis
Could Amgen's Next Drug Be Worth $100 Billion?
Amgen hopes it will win an FDA green light for evolocumab, a nextgeneration cholesterol fighter, which could grab a big chunk of the global statin market